ITonis Long-term Debt
Long-Term Debt of ITonis (ITNS) as of Oct 19, 2026.
Get this data via API
Financial Data API
Long-term Debt
-USD
Last updated:
Long-Term Debt of ITonis is 2026 - USD. Long-Term Debt of ITonis was 2025 - USD. It decreases by % lower compared to the previous year.
The ITonis Long-term Debt history
| YEAR | Long-term Debt | YoY |
|---|---|---|
| 0.00USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
ITonis Stock analysis
What does ITonis do? ITonis Inc, with ticker ITNS and ISIN US4657331033, is a U.S.-based company headquartered in Lake Forest. It operates within the Health Care sector, specifically in the Pharmaceuticals industry. The company conducted its initial public offering on February 21, 2007. ITonis Inc distributes homeopathic anti-nausea products to the medical and pharmaceutical industry. Through its Itonis Pharmaceuticals division, the company produces and markets over-the-counter and prescription homeopathic preparations designed to treat common ailments and chronic diseases. Its primary product, Emesyl, is a nausea relief solution targeted at the general public. Emesyl is available for purchase through Amazon.com and the company's website, Emesyl.com. The company's subsidiary structure includes Itonis Holdings, Inc. and Paramount Discoveries, Inc. ITonis Inc does not provide specific details regarding its revenue, market share, or the exact scope of its operations beyond the product distribution and marketing described. The company's website is listed as http://itonisholdings.com/. ITonis is one of the most popular companies on Eulerpool.
Frequently Asked Questions about ITonis stock
On Eulerpool you can find the complete historical development of Long-Term Debt ITonis since 2006 – with annual values, charts, and detailed analysis.
Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.
Long-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's ITonis historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — ITonis
Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
All Key Metrics — ITonis
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth